We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Silence Therapeutics Plc | LSE:SLN | London | Ordinary Share | GB00B9GTXM62 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 535.00 | 521.00 | 524.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMSLN
RNS Number : 9259Z
Silence Therapeutics PLC
01 June 2016
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) -------------------------------------------------- 1. Identity of the issuer or SILENCE THERAPEUTICS PLC the underlying issuer of existing shares to which voting rights are attached: (ii) ----------------------------------------------------------- -------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): --------------------------------------------------------------------------------------- An acquisition or disposal of voting rights X ------------------------------------------------------------ ------------------------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ------------------------------------------------------------ ------------------------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ------------------------------------------------------------ ------------------------- An event changing the breakdown of voting rights ------------------------------------------------------------ ------------------------- Other (please specify): ---------------------------------------------------------- ------------------------- 3. Full name of person(s) ROBERT KEITH subject to the notification obligation: (iii) ----------------------------------------------------------- -------------------------- 4. Full name of shareholder(s) AS ABOVE (if different from 3.):(iv) ----------------------------------------------------------- -------------------------- 5. Date of the transaction 27/05/2016 and date on which the threshold is crossed or reached: (v) ----------------------------------------------------------- -------------------------- 6. Date on which issuer 01/06/2016 notified: ----------------------------------------------------------- -------------------------- 7. Threshold(s) that is/are crossed or reached: (vi, vii) 18% to 19% ----------------------------------------------------------- -------------------------- 8. Notified details: ------------------------------------------------------------------------------------------------------------------------ A: Voting rights attached to shares (viii, ix) ------------------------------------------------------------------------------------------------------------------------ Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE -------------- -------------------------------- ---------------------------------------------------------------------- Number Number Number Number of % of voting of of of shares voting rights (x) Shares Voting rights Rights -------------- --------------- --------------- ------------- -------------------------- --------------------------- Direct Direct Indirect Direct Indirect (xi) (xii) -------------- ----------- ----------- ------------- ------------- ----------- ------------ ------------- GB00B9GTXM62 11,857,949 11,857,949 12,057,949 12,057,949 17.27% --------------- --------------- ------------- --------------- --------- ------------ ------------- B: Qualifying Financial Instruments ------------------------------------------------------------------------------------------------------------------------ Resulting situation after the triggering transaction ------------------------------------------------------------------------------------------------------------------------ Type of financial Expiration Exercise/ Number of voting % of voting instrument date Conversion rights that rights (xiii) Period (xiv) may be acquired if the instrument is exercised/ converted. ------------------ ------------- ------------------------------ ---------------------------- ----------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ------------------------------------------------------------------------------------------------------------------------ Resulting situation after the triggering transaction ------------------------------------------------------------------------------------------------------------------------ Type of Exercise Expiration Exercise/ Number of voting % of voting financial price date Conversion rights instrument rights (xix, instrument (xvii) period refers to xx) (xviii) ---------------- ------------- ------------- --------------- ---------------------------- ------------------------- Spreadbet Nominal Delta ---------------- ------------- ------------- --------------- ------------ ----------- 1,289,521 1.85% -------------- ----------- ----------- ----------- ---------------------------- ------------ ----------- Total (A+B+C) ------------------------------------------------------------------------------------------------------------------------ Number of voting rights Percentage of voting rights -------------------------------------------------- -------------------------------------------------------------------- 13,347,470 19.12% -------------------------------------------------- -------------------------------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) ----------------------------------------------------------------------------- Proxy Voting: ----------------------------------------------------------------------------- 10. Name of the proxy holder: ------------------------------------------------------------- -------------- 11. Number of voting rights proxy holder will cease to hold: ------------------------------------------------------------- -------------- 12. Date on which proxy holder will cease to hold voting rights: ------------------------------------------------------------- -------------- 13. Additional information: ------------------------------------------------------------- -------------- 14. Contact name: REEMA MARU ------------------------------------------------------------- -------------- 15. Contact telephone number: 0207 496 3094 ------------------------------------------------------------- --------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUAUORNKANRAR
(END) Dow Jones Newswires
June 01, 2016 09:35 ET (13:35 GMT)
1 Year Silence Therapeutics Chart |
1 Month Silence Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions